MedTrace Logo

ECT/Succinylcholine: Biochemical, Serum and Cardiovascular Changes

NCT00750906 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 13

Last updated 2020-01-18

No results posted yet for this study

Summary

This study will be conducted to determine the pharmacodynamics, cardiovascular and biochemical effects of succinylcholine when given during electroconvulsive therapy. (ECT). This is a single center, prospective, study in patients who will be receiving ECT as indicated and prescribed by their psychiatrist. The study will be performed twice on each patient, 48-72 hours apart during consecutively scheduled ECT procedures.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Ronald D Miller, MD · University of California, San Francisco

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2015-04-30
Completion
2015-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00750906 on ClinicalTrials.gov